Many sickle cell patients face impossible choice with new gene therapies

The high risk of infertility will temper sickle cell patients' embrace of new gene therapy cures such as the CRISPR drug Casgevy.

December 6, 2023 Check out STAT+

Sponsored By

Molly Ferguson for STAT New gene therapies confront many sickle cell patients with an impossible choice: a cure or fertility The high risk of infertility will temper sickle cell patients' embrace of new gene therapy cures such as the CRISPR drug Casgevy. By Megan Molteni STAT+ | Using AI, scientists create blood test that measures organ aging and predicts disease risk The findings suggest it might be possible one day to use a blood test to flag people at high risk for different organ-specific diseases. By Megan Molteni 'Last roll of the dice' for a near-term HIV vaccine fails A trial hailed as the last hope for an HIV vaccine this decade was shut down after a monitoring board found there was little chance of success. By Jason Mast Cydni Elledge/The New York Times STAT+ | Opinion: A bold approach to pay for weight loss drugs for everyone who needs them Medicare is facing disaster in the form of metabolic disease. New weight loss drugs like Wegovy can help, with a new approach to pricing. By Jeremy L. Shane Getting the lead out of the water supply: How one health expert crunched the numbers and prodded the EPA An environmental health expert published a new cost-benefit analysis, and the EPA issued a more ambitious proposal to replace lead pipes. By Annalisa Merelli STAT+ | Using Pap smears for earlier ovarian cancer detection shows promise in small new study New research used cells from routine Pap tests and found that detecting ovarian cancer as much as nine years before a diagnosis was possible. By Elizabeth Cooney Opinion: Listen: Rep. Raul Ruiz on going from the emergency room to Congress Rep. Raul Ruiz discusses future pandemic preparedness, what politicians can learn from doctors, and more on the "First Opinion Podcast." By Torie Bosch

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser